TICAM-1/TRIF associates with Act1 and suppresses IL-17 receptor–mediated inflammatory responses
TICAM-1/TRIF, a TLR3 adaptor molecule, associates with Act1 to inhibit the interaction between IL-17RA and Act1, resulting in attenuated IL-17-mediated inflammatory responses. TICAM-1 (also called TRIF) is the sole adaptor of TLR3 that recognizes double-stranded RNA. Here, we report that TICAM-1 is...
Gorde:
| Egile Nagusiak: | , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Life Science Alliance LLC
2022-02-01
|
| Saila: | Life Science Alliance |
| Sarrera elektronikoa: | https://www.life-science-alliance.org/lookup/doi/10.26508/lsa.202101181 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|